# Nitrite Infusion Studies

> **NCT00102271** · PHASE1 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oxypurinol
- **DRUG:** Sodium Nitrite

## Key facts

- **NCT ID:** NCT00102271
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-19
- **Primary completion:** —
- **Final completion:** 2011-04-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102271, "Nitrite Infusion Studies". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00102271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*